Clinical Trial

EmboTrap ® II Revascularization Device (Neuravi) in Acute Ischemic Stroke

Recruiting
View on ClinicalTrials.gov →
Summary
The primary aim of Registrap study is to assess the safety and effectiveness of the EmboTrap®II Clot Retriever device (Neuravi) in patients with acute ischemic stroke from large vessel occlusion.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2018-07-24; most recent amendment 2026-04-13.
Status change: Not Yet Recruiting → Recruiting 2022-01-22
Trial Details
NCT Number NCT03601702
Lead Sponsor Niguarda Hospital
Collaborators: Neuravi Limited
Conditions Acute Ischemic Stroke
Enrollment 100 participants
Start Date 2022-01-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2027-06-15 (estimated)
Updated on ClinicalTrials.gov 2026-04-16